E
Skinvisible, Inc.
SKVI
$0.58
$0.047.41%
E
Sell
3/14/2023Downgrade
Skinvisible, Inc. (SKVI) was downgraded to E+ from D on 3/14/2023 due to a decline in the total return index.
Skinvisible, Inc. (SKVI) was downgraded to E+ from D on 3/14/2023 due to a decline in the total return index.
D
Sell
2/9/2023Upgraded
Skinvisible, Inc. (SKVI) was upgraded to D from E+ on 02/09/2023.
Skinvisible, Inc. (SKVI) was upgraded to D from E+ on 02/09/2023.
E
Sell
2/8/2023Downgrade
Skinvisible, Inc. (SKVI) was downgraded to E+ from D on 2/8/2023 due to a significant decline in the growth index and total return index. EBIT declined 247.91% from $86 to -$127.2, operating cash flow declined 120% from $164.5 to -$32.9, and earnings per share declined from -$0.0422 to -$0.0921.
Skinvisible, Inc. (SKVI) was downgraded to E+ from D on 2/8/2023 due to a significant decline in the growth index and total return index. EBIT declined 247.91% from $86 to -$127.2, operating cash flow declined 120% from $164.5 to -$32.9, and earnings per share declined from -$0.0422 to -$0.0921.
D
Sell
5/16/2022Upgraded
Skinvisible, Inc. (SKVI) was upgraded to D from E+ on 5/16/2022 due to an increase in the volatility index.
Skinvisible, Inc. (SKVI) was upgraded to D from E+ on 5/16/2022 due to an increase in the volatility index.
E
Sell
5/13/2022Downgrade
Skinvisible, Inc. (SKVI) was downgraded to E+ from D on 05/13/2022.
Skinvisible, Inc. (SKVI) was downgraded to E+ from D on 05/13/2022.
D
Sell
5/4/2022Upgraded
Skinvisible, Inc. (SKVI) was upgraded to D from E+ on 05/04/2022.
Skinvisible, Inc. (SKVI) was upgraded to D from E+ on 05/04/2022.
E
Sell
5/1/2022Downgrade
Skinvisible, Inc. (SKVI) was downgraded to E+ from D on 5/1/2022 due to a decline in the total return index and volatility index.
Skinvisible, Inc. (SKVI) was downgraded to E+ from D on 5/1/2022 due to a decline in the total return index and volatility index.
D
Sell
4/21/2022Upgraded
Skinvisible, Inc. (SKVI) was upgraded to D from E+ on 4/21/2022 due to an increase in the total return index.
Skinvisible, Inc. (SKVI) was upgraded to D from E+ on 4/21/2022 due to an increase in the total return index.
E
Sell
4/20/2022Downgrade
Skinvisible, Inc. (SKVI) was downgraded to E+ from D on 4/20/2022 due to a noticeable decline in the total return index and solvency index. Debt to equity increased from -0.58 to -0.57.
Skinvisible, Inc. (SKVI) was downgraded to E+ from D on 4/20/2022 due to a noticeable decline in the total return index and solvency index. Debt to equity increased from -0.58 to -0.57.
D
Sell
11/9/2021Upgraded
Skinvisible, Inc. (SKVI) was upgraded to D from E+ on 11/9/2021 due to an increase in the volatility index.
Skinvisible, Inc. (SKVI) was upgraded to D from E+ on 11/9/2021 due to an increase in the volatility index.
E
Sell
11/8/2021Downgrade
Skinvisible, Inc. (SKVI) was downgraded to E+ from D on 11/8/2021 due to a decline in the volatility index and valuation index.
Skinvisible, Inc. (SKVI) was downgraded to E+ from D on 11/8/2021 due to a decline in the volatility index and valuation index.
D
Sell
8/16/2021Upgraded
Skinvisible, Inc. (SKVI) was upgraded to D from D- on 8/16/2021 due to an increase in the total return index.
Skinvisible, Inc. (SKVI) was upgraded to D from D- on 8/16/2021 due to an increase in the total return index.
D
Sell
6/16/2021Downgrade
Skinvisible, Inc. (SKVI) was downgraded to D- from D on 6/16/2021 due to a major decline in the growth index. EBIT declined 1,542.86% from $7.7 to -$111.1, operating cash flow declined 151.99% from $30.2 to -$15.7, and total revenue declined 90.88% from $132.7 to $12.1.
Skinvisible, Inc. (SKVI) was downgraded to D- from D on 6/16/2021 due to a major decline in the growth index. EBIT declined 1,542.86% from $7.7 to -$111.1, operating cash flow declined 151.99% from $30.2 to -$15.7, and total revenue declined 90.88% from $132.7 to $12.1.
D
Sell
2/16/2021Upgraded
Skinvisible, Inc. (SKVI) was upgraded to D from D- on 2/16/2021 due to a noticeable increase in the total return index.
Skinvisible, Inc. (SKVI) was upgraded to D from D- on 2/16/2021 due to a noticeable increase in the total return index.
D
Sell
2/1/2021Downgrade
Skinvisible, Inc. (SKVI) was downgraded to D- from D on 2/1/2021 due to a decline in the total return index.
Skinvisible, Inc. (SKVI) was downgraded to D- from D on 2/1/2021 due to a decline in the total return index.
D
Sell
1/13/2021Upgraded
Skinvisible, Inc. (SKVI) was upgraded to D from D- on 1/13/2021 due to an increase in the total return index and volatility index.
Skinvisible, Inc. (SKVI) was upgraded to D from D- on 1/13/2021 due to an increase in the total return index and volatility index.
D
Sell
11/27/2020Downgrade
Skinvisible, Inc. (SKVI) was downgraded to D- from D on 11/27/2020 due to a substantial decline in the growth index and solvency index. EBIT declined 826.56% from -$12.8 to -$118.6, operating cash flow declined 139.96% from $52.3 to -$20.9, and total revenue declined 94.33% from $120 to $6.8.
Skinvisible, Inc. (SKVI) was downgraded to D- from D on 11/27/2020 due to a substantial decline in the growth index and solvency index. EBIT declined 826.56% from -$12.8 to -$118.6, operating cash flow declined 139.96% from $52.3 to -$20.9, and total revenue declined 94.33% from $120 to $6.8.
D
Sell
8/21/2020Upgraded
Skinvisible, Inc. (SKVI) was upgraded to D from E+ on 8/21/2020 due to a significant increase in the growth index. Total revenue increased 645.34% from $16.1 to $120, operating cash flow increased 431.01% from -$15.8 to $52.3, and EBIT increased 90.15% from -$130 to -$12.8.
Skinvisible, Inc. (SKVI) was upgraded to D from E+ on 8/21/2020 due to a significant increase in the growth index. Total revenue increased 645.34% from $16.1 to $120, operating cash flow increased 431.01% from -$15.8 to $52.3, and EBIT increased 90.15% from -$130 to -$12.8.
E
Sell
8/3/2020Downgrade
Skinvisible, Inc. (SKVI) was downgraded to E+ from D- on 8/3/2020 due to a decline in the volatility index and total return index.
Skinvisible, Inc. (SKVI) was downgraded to E+ from D- on 8/3/2020 due to a decline in the volatility index and total return index.
D
Sell
7/7/2020Upgraded
Skinvisible, Inc. (SKVI) was upgraded to D- from E+ on 7/7/2020 due to a large increase in the growth index. Operating cash flow increased 81.67% from -$86.2 to -$15.8, total revenue increased 49.07% from $10.8 to $16.1, and earnings per share increased from -$0.1317 to -$0.1.
Skinvisible, Inc. (SKVI) was upgraded to D- from E+ on 7/7/2020 due to a large increase in the growth index. Operating cash flow increased 81.67% from -$86.2 to -$15.8, total revenue increased 49.07% from $10.8 to $16.1, and earnings per share increased from -$0.1317 to -$0.1.
E
Sell
5/1/2020Downgrade
Skinvisible, Inc. (SKVI) was downgraded to E+ from D on 5/1/2020 due to a significant decline in the valuation index, efficiency index and solvency index. Total capital declined 37.07% from -$481.2 to -$659.6, and debt to equity increased from -0.78 to -0.74.
Skinvisible, Inc. (SKVI) was downgraded to E+ from D on 5/1/2020 due to a significant decline in the valuation index, efficiency index and solvency index. Total capital declined 37.07% from -$481.2 to -$659.6, and debt to equity increased from -0.78 to -0.74.
D
Sell
5/20/2019Downgrade
Skinvisible, Inc. (SKVI) was downgraded to D from D+ on 5/20/2019 due to a decline in the total return index, volatility index and valuation index.
Skinvisible, Inc. (SKVI) was downgraded to D from D+ on 5/20/2019 due to a decline in the total return index, volatility index and valuation index.
D
Sell
4/17/2019Downgrade
Skinvisible, Inc. (SKVI) was downgraded to D+ from C- on 4/17/2019 due to a significant decline in the growth index, total return index and volatility index. Operating cash flow declined 379.75% from $15.8 to -$44.2, earnings per share declined from $0.2196 to -$0.0613, and total revenue declined 31.55% from $18.7 to $12.8.
Skinvisible, Inc. (SKVI) was downgraded to D+ from C- on 4/17/2019 due to a significant decline in the growth index, total return index and volatility index. Operating cash flow declined 379.75% from $15.8 to -$44.2, earnings per share declined from $0.2196 to -$0.0613, and total revenue declined 31.55% from $18.7 to $12.8.
C
Hold
1/7/2019Downgrade
Skinvisible, Inc. (SKVID) was downgraded to C- from C on 1/7/2019 due to a major decline in the efficiency index, total return index and valuation index.
Skinvisible, Inc. (SKVID) was downgraded to C- from C on 1/7/2019 due to a major decline in the efficiency index, total return index and valuation index.
C
Hold
9/25/2018Upgraded
Skinvisible, Inc. (SKVI) was upgraded to C from D+ on 9/25/2018 due to a major increase in the total return index and volatility index.
Skinvisible, Inc. (SKVI) was upgraded to C from D+ on 9/25/2018 due to a major increase in the total return index and volatility index.
D
Sell
8/3/2018Downgrade
Skinvisible, Inc. (SKVI) was downgraded to D+ from C- on 8/3/2018 due to a major decline in the total return index and volatility index.
Skinvisible, Inc. (SKVI) was downgraded to D+ from C- on 8/3/2018 due to a major decline in the total return index and volatility index.
C
Hold
6/29/2018Downgrade
Skinvisible, Inc. (SKVI) was downgraded to C- from C on 6/29/2018 due to a decline in the volatility index and valuation index.
Skinvisible, Inc. (SKVI) was downgraded to C- from C on 6/29/2018 due to a decline in the volatility index and valuation index.
C
Hold
6/14/2018Upgraded
Skinvisible, Inc. (SKVI) was upgraded to C from C- on 6/14/2018 due to a noticeable increase in the total return index, volatility index and valuation index.
Skinvisible, Inc. (SKVI) was upgraded to C from C- on 6/14/2018 due to a noticeable increase in the total return index, volatility index and valuation index.
C
Hold
4/23/2018Downgrade
Skinvisible, Inc. (SKVI) was downgraded to C- from C on 4/23/2018 due to a significant decline in the total return index and volatility index.
Skinvisible, Inc. (SKVI) was downgraded to C- from C on 4/23/2018 due to a significant decline in the total return index and volatility index.
C
Hold
9/21/2017Upgraded
Skinvisible, Inc. (SKVI) was upgraded to C from C- on 9/21/2017 due to a large increase in the total return index and volatility index.
Skinvisible, Inc. (SKVI) was upgraded to C from C- on 9/21/2017 due to a large increase in the total return index and volatility index.
C
Hold
8/2/2017Downgrade
Skinvisible, Inc. (SKVI) was downgraded to C- from C on 8/2/2017 due to a significant decline in the total return index and volatility index.
Skinvisible, Inc. (SKVI) was downgraded to C- from C on 8/2/2017 due to a significant decline in the total return index and volatility index.
C
Hold
4/18/2017Upgraded
Skinvisible, Inc. (SKVI) was upgraded to C from C- on 4/18/2017 due to a substantial increase in the total return index, efficiency index and growth index. Total revenue increased 52.38% from $16.8 to $25.6, EBIT increased 24.1% from -$201.7 to -$153.1, and total capital increased 4.04% from -$1.31M to -$1.25M.
Skinvisible, Inc. (SKVI) was upgraded to C from C- on 4/18/2017 due to a substantial increase in the total return index, efficiency index and growth index. Total revenue increased 52.38% from $16.8 to $25.6, EBIT increased 24.1% from -$201.7 to -$153.1, and total capital increased 4.04% from -$1.31M to -$1.25M.
C
Hold
2/21/2017Upgraded
Skinvisible, Inc. (SKVI) was upgraded to C- from D+ on 2/21/2017 due to a significant increase in the total return index, volatility index and efficiency index.
Skinvisible, Inc. (SKVI) was upgraded to C- from D+ on 2/21/2017 due to a significant increase in the total return index, volatility index and efficiency index.
D
Sell
9/20/2016Upgraded
Skinvisible Inc. (SKVI) was upgraded to D+ from D on 9/20/2016 due to a noticeable increase in the growth index, efficiency index and total return index. Operating cash flow increased 81.03% from -$77.5 to -$14.7, EBIT increased 44.99% from -$314.1 to -$172.8, and total revenue increased 34.63% from $28.3 to $38.1.
Skinvisible Inc. (SKVI) was upgraded to D+ from D on 9/20/2016 due to a noticeable increase in the growth index, efficiency index and total return index. Operating cash flow increased 81.03% from -$77.5 to -$14.7, EBIT increased 44.99% from -$314.1 to -$172.8, and total revenue increased 34.63% from $28.3 to $38.1.
D
Sell
6/15/2016Downgrade
Skinvisible Inc. (SKVI) was downgraded to D from D+ on 6/15/2016 due to a noticeable decline in the total return index and volatility index.
Skinvisible Inc. (SKVI) was downgraded to D from D+ on 6/15/2016 due to a noticeable decline in the total return index and volatility index.
D
Sell
5/24/2016Upgraded
Skinvisible Inc. (SKVI) was upgraded to D+ from D on 5/24/2016 due to a significant increase in the efficiency index.
Skinvisible Inc. (SKVI) was upgraded to D+ from D on 5/24/2016 due to a significant increase in the efficiency index.
D
Sell
3/11/2016Downgrade
Skinvisible Inc. (SKVI) was downgraded to D from D+ on 3/11/2016 due to a large decline in the volatility index and total return index.
Skinvisible Inc. (SKVI) was downgraded to D from D+ on 3/11/2016 due to a large decline in the volatility index and total return index.
D
Sell
3/1/2016Downgrade
Skinvisible Inc. (SKVI) was downgraded to D+ from C- on 3/1/2016 due to a substantial decline in the volatility index.
Skinvisible Inc. (SKVI) was downgraded to D+ from C- on 3/1/2016 due to a substantial decline in the volatility index.
C
Hold
1/15/2016Downgrade
Skinvisible Inc. (SKVI) was downgraded to C- from C on 1/15/2016 due to a major decline in the total return index and volatility index.
Skinvisible Inc. (SKVI) was downgraded to C- from C on 1/15/2016 due to a major decline in the total return index and volatility index.
C
Hold
12/31/2015Upgraded
Skinvisible Inc. (SKVI) was upgraded to C from C- on 12/31/2015 due to a noticeable increase in the total return index and growth index.
Skinvisible Inc. (SKVI) was upgraded to C from C- on 12/31/2015 due to a noticeable increase in the total return index and growth index.
C
Hold
9/28/2015Upgraded
Skinvisible Inc. (SKVI) was upgraded to C- from D+ on 9/28/2015 due to a large increase in the volatility index and total return index.
Skinvisible Inc. (SKVI) was upgraded to C- from D+ on 9/28/2015 due to a large increase in the volatility index and total return index.
D
Sell
8/14/2015Downgrade
Skinvisible Inc. (SKVI) was downgraded to D+ from C on 8/14/2015 due to a significant decline in the efficiency index, total return index and growth index. Operating cash flow declined 39.22% from -$309.3 to -$188, total revenue declined 25.48% from $73.4 to $54.7, and earnings per share declined from -$0.0045 to -$0.0044.
Skinvisible Inc. (SKVI) was downgraded to D+ from C on 8/14/2015 due to a significant decline in the efficiency index, total return index and growth index. Operating cash flow declined 39.22% from -$309.3 to -$188, total revenue declined 25.48% from $73.4 to $54.7, and earnings per share declined from -$0.0045 to -$0.0044.
C
Hold
5/15/2015Upgraded
Skinvisible Inc. (SKVI) was upgraded to C from C- on 5/15/2015 due to a significant increase in the efficiency index, growth index and valuation index. Total revenue increased 439.71% from $13.6 to $73.4, and total capital increased 217.35% from -$122.8 to -$389.7.
Skinvisible Inc. (SKVI) was upgraded to C from C- on 5/15/2015 due to a significant increase in the efficiency index, growth index and valuation index. Total revenue increased 439.71% from $13.6 to $73.4, and total capital increased 217.35% from -$122.8 to -$389.7.
C
Hold
12/15/2014Downgrade
Skinvisible Inc. (SKVI) was downgraded to C- from C on 12/15/2014 due to a large decline in the total return index.
Skinvisible Inc. (SKVI) was downgraded to C- from C on 12/15/2014 due to a large decline in the total return index.
C
Hold
11/28/2014Upgraded
Skinvisible Inc. (SKVI) was upgraded to C from C- on 11/28/2014 due to a significant increase in the total return index.
Skinvisible Inc. (SKVI) was upgraded to C from C- on 11/28/2014 due to a significant increase in the total return index.
C
Hold
8/8/2014Downgrade
Skinvisible Inc. (SKVI) was downgraded to C- from C on 8/8/2014 due to a significant decline in the efficiency index, growth index and solvency index. The quick ratio declined from 0.09 to 0.04, and total revenue declined 11% from $10 to $8.9.
Skinvisible Inc. (SKVI) was downgraded to C- from C on 8/8/2014 due to a significant decline in the efficiency index, growth index and solvency index. The quick ratio declined from 0.09 to 0.04, and total revenue declined 11% from $10 to $8.9.
C
Hold
5/13/2014Upgraded
Skinvisible Inc. (SKVI) was upgraded to C from D+ on 5/13/2014 due to a significant increase in the efficiency index, valuation index and total return index. Net income increased 10.04% from -$313.7 to -$345.2.
Skinvisible Inc. (SKVI) was upgraded to C from D+ on 5/13/2014 due to a significant increase in the efficiency index, valuation index and total return index. Net income increased 10.04% from -$313.7 to -$345.2.
OTC PK
02/28/2025 8:30AM Eastern
Quotes delayed
